The post Roundhill Submits XRP Covered Call ETF Update, Key Details for XRP Investors appeared on BitcoinEthereumNews.com. The post Roundhill Submits XRP CoveredThe post Roundhill Submits XRP Covered Call ETF Update, Key Details for XRP Investors appeared on BitcoinEthereumNews.com. The post Roundhill Submits XRP Covered

Roundhill Submits XRP Covered Call ETF Update, Key Details for XRP Investors

The post Roundhill Submits XRP Covered Call ETF Update, Key Details for XRP Investors appeared first on Coinpedia Fintech News

Roundhill Investments, a U.S.-based firm known for launching new ETF products, has filed an updated XRP-related ETF document with the U.S. SEC. 

While some view it as a significant step forward for Ripple’s XRP, the filing also comes with limitations that investors need to be aware of. 

Here’s what the Roundhill updated filing actually means.

Roundhill Field Post-Effective Amendment for XRP Covered ETF      

According to a filing submitted to the U.S. Securities and Exchange Commission on December 30, 2025, Roundhill ETF Trust filed a Rule 485 amendment for its XRP Covered Call Strategy ETF.

This filing shows that XRP is now accepted as a base asset for regulated ETF strategies, marking an important step for XRP in traditional finance.

However, this filing does not create a spot XRP ETF, and it does not mean the fund will directly hold XRP tokens.

Instead, Roundhill’s ETF is designed to earn income by using options premiums linked to other XRP-based ETFs. In simple words, it focuses on making steady returns from XRP price movement rather than owning XRP itself.

Why does the Update Filing Say?

The filing clearly states that the update was made solely to delay the ETF’s launch date, not to modify its operational structure. This means the ETF structure is already ready, and approval is not the issue, the only missing piece is the timing of when it will go live.

Even though this is not a spot ETF, the filing still sends a strong message. It confirms that XRP is accepted as a base asset for regulated ETF products. 

Moves like this usually happen after an asset passes key regulatory and structural checks, making it an important step forward for XRP.

Will Roundhill Go For the Actual XRP ETF in the Future

Roundhill’s strategy is focused on earning a steady income from XRP volatility, not betting on price growth. Still, this move adds credibility to XRP’s role in regulated financial products.

While many in the XRP community hoped this amendment might lead to a spot XRP ETF, that is not currently the case.

Following this news, the XRP token price has seen a slight jump, currently trading around $1.87. 

Source: https://coinpedia.org/news/roundhill-submits-xrp-covered-call-etf-update-key-details-for-xrp-investors/

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.8292
$1.8292$1.8292
-1.63%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Share
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Share
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29